Camillo Almici

Dr. Camillo Almici

orcid

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2014 in The Lancet Oncology
Verified
Journal Article
Closed access
FBFrancois-Clement Bidard
Francois-Clement Bidard
DPDieter J Peeters
Dieter J Peeters
TFTanja Fehm
Tanja Fehm
FNFranco Nolé
Franco Nolé
RGRafael Gisbert-Criado
Rafael Gisbert-Criado
SMStefan Michiels
Stefan Michiels

1 February 2019 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
MCMassimo Cristofanilli
Massimo Cristofanilli
JPJean-Yves Pierga
Jean-Yves Pierga
JRJames M Reuben
James M Reuben
ARAlfred Rademaker
Alfred Rademaker
ADAndrew Davis
Andrew Davis
KPKlaus Pantel
Klaus Pantel

15 July 2003 in Blood
Verified
Journal Article
Closed access
PDF file
NGNicola Giuliani
Nicola Giuliani
SCSimona Colla
Simona Colla
MLMirca Lazzaretti
Mirca Lazzaretti
RSRoberto Sala
Roberto Sala
GRGiovanni Roti
Giovanni Roti
VRVittorio Rizzoli
Vittorio Rizzoli
Patients with multiple myeloma (MM) have increased bone marrow (BM) angiogenesis; however, the proangiogenic properties of myeloma cells and the mechanisms of MM-induced angiogenesis are not completely clarified. The angiopoietin system has been identified as critical in the regulation of vessel formation. In this study we have demonstrated that myeloma cells express several proangiogenic factors, and, in particular, we found that angiopoietin-1 (Ang-1), but not its antagonist Ang-2, was expressed by several human myeloma cell lines (HMCLs) at the mRNA and the protein levels. In a transwell coculture system, we observed that myeloma cells up-regulated the Ang-1 receptor Tie2 in human BM endothelial cells. Moreover, in an experimental model of angiogenesis, the conditioned medium of HMCLs significantly stimulated vessel formation compared with control or vascular endothelial growth factor (VEGF) treatment. The presence of anti-Tie2 blocking antibody completely blunted the proangiogenic effect of XG-6. Finally, our in vitro results were supported by the in vivo finding of Ang-1, but not Ang-2, mRNA and protein expression in purified MM cells obtained from approximately 47% of patients and by high BM angiogenesis in patients with MM positive for Ang-1, suggesting that the angiopoietin system could be involved, at least in part, in MM-induced angiogenesis.

1 November 2012 in European Journal of Cancer
Verified
Journal Article
Closed access
MBMichela Buglione
Michela Buglione
SGSalvatore Grisanti
Salvatore Grisanti
CACamillo Almici
Camillo Almici
Monica MangoniMonica Mangoni
Monica Mangoni
CPCaterina Polli
Caterina Polli
SMStefano Magrini
Stefano Magrini

1 June 2011 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
NPNicola Pratesi
Nicola Pratesi
Monica MangoniMonica Mangoni
Monica Mangoni
IMIrene Mancini
Irene Mancini
FPFabiola Paiar
Fabiola Paiar
LSLisa Simi
Lisa Simi
COClaudio Orlando
Claudio Orlando

1 January 2019 in Journal of Tissue Engineering
Verified
Journal Article
Open access
PDF file
Federica ReFederica Re
Federica Re
Luciana SartoreLuciana Sartore
Luciana Sartore
VMVladimira Moulisova
Vladimira Moulisova
MCMarco Cantini
Marco Cantini
CACamillo Almici
Camillo Almici
Domenico RussoDomenico Russo
Domenico Russo
Bone marrow and adipose tissue human mesenchymal stem cells were seeded in highly performing 3D gelatin–chitosan hybrid hydrogels of varying chitosan content in the presence of human platelet lysate and evaluated for their proliferation and osteogenic differentiation. Both bone marrow and adipose tissue human mesenchymal stem cells in gelatin–chitosan hybrid hydrogel 1 (chitosan content 8.1%) or gelatin–chitosan hybrid hydrogel 2 (chitosan 14.9%) showed high levels of viability (80%–90%), and their proliferation and osteogenic differentiation was significantly higher with human platelet lysate compared to fetal bovine serum, particularly in gelatin–chitosan hybrid hydrogel 1. Mineralization was detected early, after 21 days of culture, when human platelet lysate was used in the presence of osteogenic stimuli. Proteomic characterization of human platelet lysate highlighted 59 proteins mainly involved in functions related to cell adhesion, cellular repairing mechanisms, and regulation of cell differentiation. In conclusion, the combination of our gelatin–chitosan hybrid hydrogels with hPL represents a promising strategy for bone regenerative medicine using human mesenchymal stem cells.